The estimated Net Worth of Stephen Michael Kelsey is at least $17.6 Milion dollars as of 13 August 2024. Dr Kelsey owns over 16,667 units of Revolution Medicines Inc stock worth over $11,903,928 and over the last 16 years he sold RVMD stock worth over $4,942,183. In addition, he makes $773,033 as Pres of R&D at Revolution Medicines Inc.
Dr has made over 31 trades of the Revolution Medicines Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 16,667 units of RVMD stock worth $68,168 on 13 August 2024.
The largest trade he's ever made was exercising 39,900 units of Revolution Medicines Inc stock on 28 September 2020 worth over $188,727. On average, Dr trades about 6,583 units every 108 days since 2009. As of 13 August 2024 he still owns at least 285,740 units of Revolution Medicines Inc stock.
You can see the complete history of Dr Kelsey stock trades at the bottom of the page.
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. is the Pres of R&D at Revolution Medicines Inc.
As the Pres of R&D of Revolution Medicines Inc, the total compensation of Dr D at Revolution Medicines Inc is $773,033. There are 4 executives at Revolution Medicines Inc getting paid more, with Mark Goldsmith having the highest compensation of $4,576,250.
Dr D is 60, he's been the Pres of R&D of Revolution Medicines Inc since . There are 1 older and 15 younger executives at Revolution Medicines Inc. The oldest executive at Revolution Medicines Inc is Elizabeth Anderson, 62, who is the Independent Director.
Stephen's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY, CA, 94063.
Over the last 5 years, insiders at Revolution Medicines Inc have traded over $249,645,422 worth of Revolution Medicines Inc stock and bought 3,371,315 units worth $74,500,278 . The most active insiders traders include Peter Svennilson, Thilo Schroeder oraz Rock Ventures Ii, L.P.Third.... On average, Revolution Medicines Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,075,216. The most recent stock trade was executed by Stephen Michael Kelsey on 13 August 2024, trading 16,667 units of RVMD stock currently worth $68,168.
revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
Revolution Medicines Inc executives and other stock owners filed with the SEC include: